GrantRound

Open Federal Grants · National Institutes of Health

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)

National Institutes of Health · Opportunity PAR-26-091 · Award amount: see the official listing

AgencyNational Institutes of Health
Opportunity NumberPAR-26-091
Award FloorNot stated in the listing
Award CeilingNot stated in the listing
Cost Sharing / MatchingNot required by the listing
Application DeadlineNo fixed deadline — see the official listing
Last Updated on Grants.govDec 8, 2025
Who Can ApplyState governments, County governments, City / township governments, Regional organizations, U.S. territories & freely associated states, Independent school districts, Federally recognized tribal governments, Public housing authorities, Native American tribal organizations, Nonprofits with 501(c)(3) status, Nonprofits without 501(c)(3) status, Private colleges / universities, For-profit organizations, Small businesses, Other applicants

Eligibility

Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organization

Eligibility text quoted from the official Grants.gov listing.

About This Opportunity

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits applications to support the validation of molecular/cellular/imaging markers (referred to as "markers" or "biomarkers") and assays for cancer detection, diagnosis, prognosis, monitoring, and prediction of response or resistance to treatment, as well as markers for cancer prevention and control. The applicants have the option of submitting either a biphasic UH2/UH3 (Developmental Cooperative Agreement …

Description from the official Grants.gov listing — read the complete notice, including any updates, on Grants.gov before applying.

Check Your Fit Get the Free Round-Up

View the official listing on Grants.gov →

More Open Grants From NIH

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)Oct 14, 2026
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed)Oct 14, 2026
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed)Oct 14, 2026
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required)Oct 14, 2026
Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed)Oct 14, 2026

Browse Open Grants

By who can apply:

Nonprofits 856Small Businesses 756State Governments 848Local & Regional Governments 821Tribal Governments & Organizations 851Schools, Colleges & Universities 865Individuals 14Open to All Applicant Types 187

By agency:

NIH 673National Science Foundation 104FDA 54CDC 52HRSA 49Defense Health Agency 47Bureau of Justice Assistance 24Indian Health Service 18NASA Headquarters 16Office of Juvenile Justice Delinquency Prevention 16HUD 15Administration for Community Living 15All agencies & the full hub →

By closing month:

October 2026 102November 2026 145December 2026 54January 2027 62February 2027 23March 2027 18April 2027 22

Every grant listed here comes from Grants.gov, the official U.S. government database. Award amounts and deadlines can change — verify the details on the official listing before you apply. GrantRound is not affiliated with the U.S. government.